The aim of this study was to evaluate intraperitoneal (IP) lidocaine administration and intravenous (IV) lidocaine infusion for postoperative pain control after cesarean section. Study design This is a prospective randomized, double-blind, placebo-controlled study. Patients and methods A total of 165 pregnant full-term women who were indicated for elective cesarean delivery for various indications were randomized equally to either group C (control, IP and IV saline), group IP (IP lidocaine administration), or group IV (IV lidocaine infusion). Five patients were excluded from each group for various reasons. The outcome measures were postoperative pain scoring, total pethidine consumption, and the need for postoperative analgesia.
Introduction
Cesarean section is the most common laparotomy procedure performed in women worldwide, and its rate is progressively increasing [1] . Postcesarean pain remains a major morbidity, and optimal pain management is a crucial challenge for obstetricians and anesthesiologists [2] .
The ideal method for postcesarean pain relief should be cost-effective, simple, and safe for the mother, providing high-quality pain relief with low incidence of side effects and complications. Also, it should not interfere with the maternal care of the newborn or with the establishment of breast-feeding, and should involve drugs that are minimally excreted into breast milk [2] . Several studies have been performed to assess the effectiveness of different postpartum pain management protocols for cesarean section. These protocols may be insufficient and unsatisfactory in some patients. Therefore, a multimodal approach to pain management including the use of nonsteroidal anti-inflammatory drugs, opioids, and local anesthetics has been suggested [3] .
Local anesthetic usage during surgery has fewer side effects in comparison with opioids or neuroaxial methods. A variety of local anesthetic techniques have been investigated to find out their potential analgesic benefits. Local anesthetic installation can be performed at the wound site in the form of incision or around the nerves as a spinal, epidural, paravertebral, or transversus abdominis plane block [4] . Preliminary reports suggested that intraperitoneal (IP) installation of local anesthetics, thereby blocking peritoneal afferents, may have a beneficial effect after gynecological laparoscopic surgery and cesarean sections [5, 6] . Also, intravenous (IV) lidocaine infusion can offer postoperative analgesia especially after abdominal surgery [7] . On the basis of these considerations this study was conducted to compare the effect of IP lidocaine installation with that of IV lidocaine injection on postoperative pain and analgesic requirements in women undergoing cesarean section.
Patients and methods
This prospective, double-blind, placebo-controlled, randomized clinical study was conducted in the Department of Obstetrics and Gynecology, Benha University Hospital, Alkalubia, Egypt, from June 2013 to December 2015. The study protocol was approved by the Local Ethics Committee, and written informed consent was taken from participants entering the study. Initially, the study included 165 women with a singleton pregnancy who had completed at least 37 gestational weeks and were indicated for elective cesarean delivery for various indications, such as primigravida with breech presentation, macrosomia, intrauterine growth restriction, and contracted pelvis, and were willing to participate in the study. Gestational age was determined on the basis of the last menstrual period, confirmed by an ultrasound before 20 weeks of gestation and calculated in menstrual weeks. Exclusion criteria were as follows: age below 18 or above 40 years, uncooperative patients, women undergoing spinal anesthesia, having previous abdominal scars, including previous cesarean or myomectomy, multiple gestation, BMI more than 35 kg/m 2 , chorioamnionitis, hypersensitivity or contraindications to lidocaine, bronchial asthma, bleeding diathesis, pregnancy-induced hypertension, liver or kidney diseases, diabetes mellitus, and patients with psychological disturbance or any form of chronic pain before or during pregnancy.
Patients were randomized according to a computergenerated random numerical table into three equal groups, each including 55 participants: group C (placebo control group): saline was given both intraperitoneally and intravenously during caesarean section; group IP (IP instillation group): patients received 1.75 ml/kg of 0.2% lidocaine (3.5 mg/kg) with parietal peritoneal closure with IV normal saline in a volume equivalent to that used in the IV lidocaine group as placebo to ensure blinding; group IV (IV injection group): patients received 1.5 mg/kg of IV 1% lidocaine as bolus dose at induction and 2 mg/kg/h as continuous infusion of IV lidocaine until one hour after surgery and 100 ml of saline intraperitoneally as placebo to ensure blinding.
The preparation and administration of the medication were carried out by a nurse who had not been involved in the management of the patient except for drug administration. Data collection sheets with corresponding codes were filled out preoperatively by the operating surgeon. These sheets were completed postoperatively by residents. Patients were evaluated for postoperative pain scoring, total pethidine consumption, and the need for postoperative analgesia. The time to bowel sounds, starting regular diet, duration of hospital stay, and any reported side effects were also noted. The allocation was revealed to both the patient and the surgeon at the end of the study.
Cesarean section technique
Cesarean section was always performed by the first author; patient follow-up was confirmed by the two other obstetricians. Cesarean section was conducted under general anesthesia (general anesthesia is indicated if the patient refuses a regional approach, if there is any clinical contraindication to neuraxial blockade -e.g. coagulopathy -or when time is of immense necessity -e.g. acute severe fatal compromise. Lack of resources, manpower, and skill, and to a lesser extent materials to insert a regional anesthetic, are further reasons for general anesthesia). Anesthesia was induced by the fourth author of this study. The skin was incised via Pfannenstiel incision, followed by blunt dissection of the subcutaneous tissues and sharp opening of the anterior rectus sheath; the rectus muscles were separated using the no-cutting procedure. Subsequently, the blunt technique was used to open and expand the parietal peritoneum, high above the bladder, and a bladder flap was created. A small median transverse lower uterine segment hysterotomy incision was made using a scalpel, and expanded bluntly on both sides. After delivery of the baby and the placenta and without exteriorization, the hysterotomy incision was closed using continuous nonlocking double layer closure. However, visceral peritoneum was left open in all patients. After closing the uterine incision the accumulated blood in the pelvis and hematomas were carefully wiped out with surgical towels, leaving a more or less dry pelvis before the fluid was instilled. The abdomen was closed in layers. Parietal peritoneum was closed using continuous nonlocking sutures. However, the rectus muscles were left nonapproximated. Closure of the subcutaneous tissue was done with single stitches. Closure of the skin was performed with a subcuticular suture. No intra-abdominal, subrectal, or subcutaneous drains were left.
Postoperative analgesia
The patient received declofenac sodium 75 ml intramuscular during the immediate postoperative period, which was repeated every 12 h for the first 24 h, with additional rescue analgesia in the form of pethidine 50 mg intramuscular given upon patient request.
Patients were monitored for side effects such as nausea, vomiting, drowsiness, and itching.
Pain scoring
All pain scores were obtained at intervals of 4, 6, 12, and 24 h after surgery. To assess pain on the first postoperative day, the visual analogue scale (VAS) was used to assess the procedure-related pain. The VAS is often presented as a horizontal 100-mm long line with verbal anchors saying no pain at one end and unbearable pain at the other end. The patient was asked to mark the line at the distance corresponding to the intensity of present pain. A VAS rating of 0-4 mm was considered as no pain; 5-44 mm was considered as mild pain; 45-74 mm as moderate pain; and 75-100 mm as severe pain. The VAS was explained to the patients before the procedure. Patients completed the VAS without the help of any staff member. Patients who could not complete it or did not want to finish it were excluded from the pain analysis. paraesthesia, itching-uncontrolled muscle contraction, convulsions, headache, hypotension, and bradycardia.
Sample size calculation
A sample size of 50 women for each group was calculated using a statistical computer program with the following parameters: probability of type 1 error, 0.05; power, 0.8; number of groups, 3; large difference to be detected among means, 0.54; and expected background SD, 1. The dropout incidence was expected to be 10% and hence 55 cases were enrolled in each group.
The statistical analysis
The collected data were tabulated and statistically analyzed using The Statistical Package for the Social Sciences (SPSS, version 15.0 for Windows; SPSS Inc., Chicago, Illinois, USA) software. Results were expressed as mean ± SD. Comparison between the mean values of different variables in the three groups was performed using analysis of variance, whereas proportions were compared using the w 2 -test. P values less than or equal to 0.05 were considered significant. Figure 1 represents the CONSORT diagram showing the flow of participants through each stage of a randomized trial. No statistical differences were noted among the three groups as regards age, weight, parity, gestational age, anesthesia time, and operation time Table 1 . Significantly reduced VAS scores were observed in groups IP and IV compared with controls after 4 h; however, this difference was not noted after 6, 12, and 24 h Table 2 .
Results
There was significantly lower total pethidine consumption in 24 h, time to ambulation, onset of pain relief, and the need for rescue analgesia in groups IV and IP compared with controls. No significant differences were noted between the groups as regards the time to bowel sounds, the time to starting a regular diet, or the period of hospital stay, although the values were lower in group IV compared with the other two groups. Postoperative nausea and vomiting were less frequently noted in groups IP and IV than in group C, but this trend was not statistically significant Table 2 .
Discussion
The current study reported that installation of lidocaine, either IP or IV, during caesarian section significantly reduced postoperative pain scores and opioid consumption. The IP installation of local anesthetics to decrease postoperative pain has been evaluated in a variety of surgical occasions. These studies have compared different types of local anesthetics and different timing of local anesthetic delivery in relation to surgery -for example, before the procedure, through continuous catheter infusion, or at the end of surgery. Several studies reported that IP lidocaine at the end of surgery was associated with lower postoperative pain scores after laparoscopic cholecystectomy (400 mg lidocaine) [8] , minor laparoscopic gynecological procedures [9] , and total abdominal hysterectomy (200 mg lidocaine) [10] . However, its use in postcesarean delivery pain was evaluated in a study reporting a decreased incidence and scores of postoperative pain following IP instillation of 200 mg of lidocaine at the end of cesarean delivery, in which the parietal peritoneum was sutured [6] . Among the several local anesthetics for postoperative pain relief currently in practice the instillation of local anesthetics intraperitoneally during caesarian section has been most promising and best adapted to our practice, because of its possible efficacy and the simplicity and ease of realization by obstetricians. However, it involves the risk of turning a localized infection into generalized peritonitis. Therefore, IV lidocaine could be used as part of a multimodal approach for the treatment of postoperative pain, particularly when IP lidocaine administration is not suitable, as in cases of serious intra-abdominal inflammatory conditions [11] .
As in the present study, other studies also reported that IV lidocaine infusion decreased opioid consumption, improved postoperative pain scores and bowel function in patients undergoing laparoscopic and abdominal surgeries, and improved the life quality postoperatively without affecting the time to discharge from the postanesthesia-care unit [12, 13] . The analgesic effect of systemic lidocaine is biphasic. It has a peripheral suppressive effect on acute chemically induced pain and a central antihyperalgesic effect [14] . The optimal method for IV lidocaine delivery has not been established yet. Large bolus lidocaine infusion was associated with a direct analgesic and morphine-sparing effect; however, continuous low-dose lidocaine infusions were effective only in postoperative pain reduction [15] . Therefore, in the present study, we used both bolus and continuous lidocaine injection to achieve a lasting analgesic effect and favorable postoperative outcomes.
The current study agreed with others that reported that lidocaine, either IP or IV, during caesarian section significantly reduced postoperative opioid consumption [6] [7] [8] [9] . Opioid consumption is not only a reflection of pain intensity but is also intensely influenced by diverse psychological factors, including anxiety level, mood, and expectation of recovery [8] .
The side effects in both lidocaine groups compared with placebo were minimal. This can be explained by the high safety profile and the minimal toxicity from commonly studied lidocaine doses, which has been well documented by previous studies [11] . Another explanation would be the lower morphine consumption among lidocaine patients, resulting in less drowsiness, nausea, vomiting, itching, and earlier mobility, as reported by the present study.
The following are some limitations of this study:
(1) Obese pregnant women with BMI more than 35 and patients receiving regional anesthesia were not included in the study. (2) The nature of postoperative pain and the VAS score that corresponded to each type of pain were not characterized.
Conclusion
IV lidocaine injection is as effective as IP instillation when compared with placebo for reducing pain and pethidine consumption and for early ambulation in women undergoing elective cesarean section. The main advantage of IV lidocaine injection is that it is an easily and universally applicable procedure compared with IP instillation.
There are no conflicts of interest. 
